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INTRODUCTION
Toxicity by oxygen radicals has been suggested as an
important cause of  cancer, heart disease and aging.1
Oxygen radicals and other oxidants are toxic mainly
because of their ability to initiate the chain reaction of
lipid peroxidation. Lipid peroxidation in turn, generates
reactive species such as radicals, hydro peroxides,
aldehydes, and epoxides with the capability of causing
cellular, DNA, and RNA injuries. 1
The protective systems against these injuries include
enzymes, such as superoxide dismutase, the selenium
containing glutathione peroxidase and antioxidants and
radical scavengers; such as α -tocopherol and β -carotene
in the lipid portion of the cell and glutathione and
ascorbic acid in the aqueous phase.1 These protective
mechanisms are now recognized as anti-carcinogenic
and even having ability to increase life-span. 1
Uric acid is the final product of purine metabolism in
humans, and its circulating concentrations are regulated
by the balance in its production and excretion2. Uric
acid is a known antioxidant, 1 and thus may prevent
cancer by mopping up free radicals that may cause
cellular and genetic injury. It is also said to help in
stabilization of ascorbate in biological fluids3, and
because its serum concentration is higher than that of
ascorbate, it is thought to potentially have a higher
antioxidant property than ascorbate. 3
Humans and other primates have higher serum urate
and lower hepatic uricase levels compared to lower
mammalian species.4 Ames et al.1 proposed that the
uric acid may act to prevent formation of  oxygen
radicals and thereby protect against carcinogenesis.
Only few studies have tested the association between
uric acid and carcinogenesis with inconsistent results5,
6 , however, to the best of our knowledge, no study
has examined the role of  uric acid in the aetiology of
oral cancer.
The aim of this study was to analyze the serum uric
acid levels in oral cancer patients and compare them
with those of  normal patients in order to examine
the possible role of  uric acid in the aetiology of  oral
cancer.
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Introduction: Toxicity by oxygen radicals has been considered
as an important cause of  cancer. It is proposed that the
antioxidant properties of uric acid may act to prevent
formation of  oxygen radicals and thereby protect against
carcinogenesis. This study aims to assess the role of uric
acid in the aetiology of  oral cancer.
Materials and Methods: Thirty one oral cancer patients and
thirty normal patients had serum uric acid measured using
spectophotometer. The data obtained was analyzed using the
Statistical Package for the Social Sciences, version 19.0
(SPSS19).  Statistical significance was determined at P < 0.05.
Results: The mean serum uric acid level in oral cancer patients
was 5.18 mg/dl (SD±1.96) while the mean was 7.09 mg/dl
(SD±1.84) for the control group and this difference was
statistically significant (p=0.000, t= -3.914, C.I. = - 2.885 to -
0.933). The risk of oral cancer was 3.98 times more in patients
who had low serum uric acid.
Conclusion: This study showed that serum uric acid was lower
in oral cancer patients compared with healthy volunteers and
low serum uric acid was associated with increased risk of
oral cancer development. However, further prospective cohort
studies are suggested to better understand the role of serum
uric acid in aetiology of  oral cancer.
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MATERIALS AND METHODS
Thirty one histological confirmed oral cancer patients
and thirty healthy volunteers were recruited from the
Out-patient department of the Dental Centre
University College Hospital Ibadan over an eighteen
months period. Ethical clearance was obtained from
the joint ethical committee of University of Ibadan
and the University College Hospital. All patients were
duly informed of  the aim of  the procedure and
consented to participate in the study. Healthy volunteers
ratio and logistic regression, where applicable. Statistical
significance was determined at P < 0.05.
RESULTS
The male to female ratio in the oral epithelial cancer
group was 1:1.7. The age range was 18 to 83 years
while the mean age was 53.7 years (SD±17.3). The
male: female ratio in the control group was 1.3:1 and
the mean age was 54.8 years (SD±10.9) while the age
range was 40-78 years. Student t test showed there
under age 40 years and all those with known systemic
diseases were excluded from the study (this is because
things like alcohol, fructose containing sugars and
purine containing foods may increase serum uric acid
levels). Patients who previously had any form of  radio
therapy, chemo therapy or surgical interventions were
excluded from the study.
10mls of intravenous blood was taken from all
participants after an overnight fast. The blood was
centrifuged at 3,000 rpm for 5 minutes and separated
serum was aspirated into tubes and analyzed for uric
acid with a DM520 spectrophotometer (Beckman
USA).
The data obtained was analyzed using the Statistical
Package for the Social Sciences, version 19.0 (SPSS19).
Differences between the two groups were analyzed
for statistical significance using the student t- test, odd
was no statistical significant difference between the
mean ages of patients with oral cancer and the control
group. (p = 0.788, t = 0.270, C.I. = - 6.337 to +8.308).
The mean serum uric acid level in oral cancer patients
was 5.18 mg/dl (SD±1.96) while the mean was 7.09
mg/dl (SD±1.84) in the control group. There was a
statistically significant difference between the mean
serum levels of oral cancer patients compared to that
of  the control group. (p=0.000, t= -3.914, C.I. = -
2.885 to -0.933).
Table 1 shows that more (16.1%) oral cancer patients
had low serum uric acid (<3 mg/dl) compared with
the control group in which only 3.3% had low serum
uric acid levels. The risk of  oral cancer was 3.98 times
more in patients who had low serum uric acid, while
tobacco and alcohol use were associated with 4.05
and 1.09 times increased risk of oral cancer respectively
(Table 2).








5(16.1) 1(3.3) 0.027* 3.98 0.076, 0.834
Alcohol intake 8(25.8) 7(24.1) 0.881 1.09 0.34, 3.53
Tobacco intake 6(23.1) 2(6.9) 0.131* 4.05 0.74, 22.20
*Fishers exact test used
Table 2: Comparison of  risk factors for oral cancer
Table 1: Serum levels in Oral cancer patients and control group






Low (<3mg/dl) 5(16.1) 1(3.3) 6(9.8)
Normal (3-6 mg/dl) 21(67.7) 16(53.3) 37(60.7)
High serum (>6 mg/dl) 5(16.1) 13(43.3) 18(29.5)
Total 31(100) 30(100) 61(100)
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DISCUSSION
This study showed that serum uric acid level was
significantly lower in oral cancer patients compared to
the control group. Previous studies showing relationship
between serum uric acid and cancer incidence have
been rather inconsistent. Mazza et al6, in a study in Italy,
found that serum uric acid could protect against cancer.
This was corroborated by Bozkir et al7 who reported
a significantly lower Serum uric acid in lung cancer
patients compared to healthy controls. In a study by
Willet et al7 in the Netherlands, 672 men aged 47-66
years were followed up for a 10 years period, found
that lower levels of  SUA were associated with lung
cancer mortality but no increase in mortality of other
cancer types. After controlling for age and smoking,
the relationship of serum uric acid to lung cancer was
significant.
Many other studies such as Strasak et al8  in Austria,
Levine et al4 in USA, Bengston et al5 and Petterson el10
all found that high serum uric acid was associated with
higher risk of  cancer mortality, although, they did not
observe serum uric acid association with cancer inci-
dence and other factors. However, Hiatt and Fireman2
in prospective cohort study, found no association be-
tween serum uric acid with cancer incidence after ad-
justing for age, race, education, tobacco, alcohol in-
take, and body mass index.
The increased risk of cancer mortality obtained in some
of these studies may be due to the markedly high serum
uric acid observed in some cancer patients, which may
be attributed to the malignant process itself, resulting
from the increased nucleic acid turnover in the rapidly
proliferating diseased tissue. 9
It is also possible that the effect of serum uric acid on
aetiology of  cancer may vary from one type of  cancer
to another; low serum uric acid may be associated
with increased risk of lung and oral cancer for instance,
while high serum uric acid may be associated with
increased risk of  other types of  cancer.
An association of low serum uric acid level with lung
cancer was thought to be plausible under the Ames
hypothesis, since the high oxygen environment of lung
tissue could be more susceptible to the carcinogenic
activity of  oxygen radicals. 4
Increased risk of prostate cancer associated with
elevated serum uric acid may be an indirect reflection
of androgen (testosterone and dihydrotestoterone)
metabolism which has been associated with increased
prostate cancer risk. These hormones are associated
with increased muscle mass and increased muscle mass
may lead to greater tissue turnover and DNA
catabolism and thus high serum uric acid levels.10 These
possibilities may be in part, responsible for the
inconsistent results gotten from studies in the
relationship between serum uric acid and cancer
incidence and mortality.
The low Serum uric acid in oral cancer patients in this
study may be due to nutritional compromise of the
patients due to Tumour necrosis Factor (TNF) and
Interleukin 6 (IL-6) produced in cancer patients, which
cause loss of appetite.10 Serum uric acid level is
determined by both endogenous production and
exogenously by ingestion from dietary sources. It is
believed that up to 50% of serum uric acid is from
dietary sources including liver, mussels, sardines and
sausages.3 Serum uric acid level is also affected by
alcohol consumption, fructose containing sugars, and
defects in purine metabolism, impaired renal function,
hyperinsulinemia, drugs such as diuretics and genetic
factors. 11,12
Although, this study does not entirely resolve the
controversy of the role of serum uric acid in cancer
aetiology, it is probably one of  the first to examine
possible role of serum uric acid in oral cancer aetio-
pathogenesis and showed that low serum uric acid is
associated with increased risk of oral cancer
development but further prospective cohort studies
are suggested to better understand the role of  serum
uric acid in aetiology of  oral cancer.
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